Skip to main content

Table 1 Baseline characteristics of two groups

From: Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer

Characteristics

Treatment group

Control group

P value

Number

21

61

 

Age (years)

   

 Mean (Range)

56.6 (32–74)

56.4 (31–74)

0.95

Gender

   

 Male

19 (90.5 %)

53 (86.9 %)

 

 Female

2 (9.5 %)

8 (13.1 %)

0.73

Clinical stage

   

 III

10 (47.6 %)

37 (60.7 %)

 

 IV

11 (52.4 %)

24 (39.3 %)

0.30

Tumor histology

   

 Adenocarcinoma

8 (38.1 %)

26 (42.6 %)

 

 Squamous carcinoma

13 (61.9 %)

35 (57.4 %)

0.72

Cycles of previous chemotherapy

2.9 ± 0.7

3.1 ± 0.8

0.53

PS score

0.4 ± 0.6

0.6 ± 0.7

0.35